Evolution of Gene Therapy in Hematology
Authors:
- Robyn LovesRLRobyn Loves
- Donald B. KohnDKDonald B. Kohn
- 30 September 2026
- journal article
- Published by Elsevier in Seminars in Hematology
Abstract
No abstract availableThis publication has 128 references indexed in Scilit:
- Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark studyJournal of Allergy and Clinical Immunology, 2023
- Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editingCell, 2023
- Therapeutic in vivo delivery of gene editing agentsCell, 2022
- Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert CommitteeJournal of Clinical Immunology, 2022
- Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP DeficiencyJournal of Clinical Immunology, 2021
- Correction of β‐thalassemia major by gene transfer in haematopoietic progenitors of pediatric patientsEMBO Molecular Medicine, 2010
- Long-term efficacy of enzyme replacement therapy for Adenosine deaminase (ADA)-deficient Severe Combined Immunodeficiency (SCID)Clinical Immunology, 2005
- Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirusCell, 1983
- Gene transfer into mouse lyoma cells by electroporation in high electric fields.The EMBO Journal, 1982
- Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirusCell, 1981